These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 21932407
21. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori M, Doki Y. Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050 [Abstract] [Full Text] [Related]
22. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
23. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma. Kawasaki Y, Okumura H, Uchikado Y, Kita Y, Sasaki K, Owaki T, Ishigami S, Natsugoe S. Ann Surg Oncol; 2014 Jul 15; 21(7):2347-52. PubMed ID: 24599410 [Abstract] [Full Text] [Related]
24. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S. Am J Gastroenterol; 2004 Sep 15; 99(9):1667-74. PubMed ID: 15330899 [Abstract] [Full Text] [Related]
26. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. Seki N, Takasu T, Sawada S, Nakata M, Nishimura R, Segawa Y, Shibakuki R, Hanafusa T, Eguchi K. Lung Cancer; 2010 Dec 15; 70(3):329-34. PubMed ID: 20621385 [Abstract] [Full Text] [Related]
27. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Laryngoscope; 2002 Dec 15; 112(12):2129-40. PubMed ID: 12461330 [Abstract] [Full Text] [Related]
28. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Lavertu P, Adelstein DJ, Myles J, Secic M. Laryngoscope; 2001 Nov 15; 111(11 Pt 1):1878-92. PubMed ID: 11801963 [Abstract] [Full Text] [Related]
30. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy. Nomura M, Shitara K, Kodaira T, Hatooka S, Mizota A, Kondoh C, Yokota T, Takahari D, Ura T, Muro K. Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):946-52. PubMed ID: 21362578 [Abstract] [Full Text] [Related]
32. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H. J Surg Oncol; 2005 May 01; 90(2):89-94. PubMed ID: 15844180 [Abstract] [Full Text] [Related]
33. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Castellvi J, Garcia A, Ruiz-Marcellan C, Hernández-Losa J, Peg V, Salcedo M, Gil-Moreno A, Ramon y Cajal S. Hum Pathol; 2009 Oct 01; 40(10):1418-26. PubMed ID: 19428047 [Abstract] [Full Text] [Related]
34. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Shih CH, Ozawa S, Ando N, Ueda M, Kitajima M. Clin Cancer Res; 2000 Mar 01; 6(3):1161-8. PubMed ID: 10741747 [Abstract] [Full Text] [Related]
36. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y. J Surg Oncol; 2009 Nov 01; 100(6):442-6. PubMed ID: 19653262 [Abstract] [Full Text] [Related]